about
Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis.Spirometry and Bronchodilator Test.The microbiome of the lung and its extracellular vesicles in nonsmokers, healthy smokers and COPD patients.Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study.Comparison of Korean COPD guideline and GOLD initiative report in term of acute exacerbation: a validation study for Korean COPD guideline.Efficacy of bronchoscopic lung volume reduction by endobronchial valves in patients with heterogeneous emphysema: report on the first Asian casesClinical characteristics and survival of Korean idiopathic pulmonary arterial hypertension patients based on vasoreactivityThree-month treatment response and exacerbation in chronic obstructive pulmonary disease.Prevalence of Spirometrically-defined Restrictive Ventilatory Defect in Korea: The Fourth-2, 3, and Fifth Korean National Health and Nutrition Examination Survey, 2008-2012Clinical Characteristics and Treatment Outcomes of Primary Pulmonary Artery Sarcoma in Korea.Safety and Effectiveness of Indacaterol in Chronic Obstructive Pulmonary Disease Patients in South Korea.Factors associated with plasma IL-33 levels in patients with chronic obstructive pulmonary diseaseAdipose stem cell-derived nanovesicles inhibit emphysema primarily via an FGF2-dependent pathway.Progranulin protects lung epithelial cells from cigarette smoking-induced apoptosis.Summary of the Chronic Obstructive Pulmonary Disease Clinical Practice Guideline Revised in 2014 by the Korean Academy of Tuberculosis and Respiratory Disease.Association of plasma adipokines with chronic obstructive pulmonary disease severity and progression.Determinants of Nicotine Dependence in Chronic Obstructive Pulmonary Disease.Valproic acid enforces the priming effect of sphingosine-1 phosphate on human mesenchymal stem cells.Effect of Indacaterol on Cough and Phlegm in Chronic Obstructive Pulmonary Disease Patients: A Meta-Analysis of Five Randomized Controlled Trials.Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away?Urinary desmosine is associated with emphysema severity and frequent exacerbation in patients with COPD.Perceptions of Severe Asthma and Asthma-COPD Overlap Syndrome Among Specialists: A Questionnaire Survey.Alternative definitions of chronic bronchitis and their correlation with CT parameters.Potential Therapeutic Strategy in Chronic Obstructive Pulmonary Disease Using Pioglitazone-Augmented Wharton's Jelly-Derived Mesenchymal Stem CellsDilemma of Asthma Treatment in Mild PatientsA novel CT-emphysema index/FEV approach of phenotyping COPD to predict mortalityGene expression profile of human lung in a relatively early stage of COPD with emphysemaBlood eosinophil count as a prognostic biomarker in COPDFactors Associated with Indacaterol Response in Tuberculosis-Destroyed Lung with Airflow LimitationBronchial Thermoplasty in Patients with Severe Uncontrolled Asthma: First Korean CasesEffects of inhaler therapy on mortality in patients with tuberculous destroyed lung and airflow limitationEffect of tiotropium inhaler use on mortality in patients with tuberculous destroyed lung: based on linkage between hospital and nationwide health insurance claims data in South KoreaEvaluation and Interpretation of Transcriptome Data Underlying Heterogeneous Chronic Obstructive Pulmonary DiseaseEpidemiology of Antiphospholipid Syndrome in Korea: a Nationwide Population-based StudyHyperuricemia Is Not Predictive of Long-Term Outcome in Patients with Stable Chronic Obstructive Pulmonary DiseaseImpact of symptom variability on clinical outcomes in COPD: analysis of a longitudinal cohortComparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancersClinical Utility of Quantitative CT Analysis for Fissure Completeness in Bronchoscopic Lung Volume Reduction: Comparison between CT and Chartis™Clinical Phenotypes, Comorbidities, and Exacerbations according to Serum 25-OH Vitamin D and Plasma Fibrinogen Levels in Chronic Obstructive Pulmonary DiseaseAdherence to roflumilast under dose-escalation strategy in Korean patients with COPD
P50
Q30274832-A665FBB2-4FED-4A43-A0E8-50733143C089Q33567337-1E177C3C-3744-4FC6-8F02-45F59DC987C0Q33646225-0C64D6A3-0AE5-4C82-B910-7DF1796A4C6BQ33766481-0A8C3408-1B3E-49E0-AB60-96637099CF8DQ34029980-654ED567-717F-46AA-8D12-F3AEF462843EQ34429562-74E5472C-A4B9-49FE-BD5F-D814EE3860A0Q34591957-5E3F2FA1-B938-4EFA-9CFA-058B5CF82DA2Q34779478-5953912B-E887-4E6F-97CA-8A303E0D8E8AQ35649126-5E42C204-C29E-44AA-84C9-7F864B546ABBQ37323421-30C46B29-0D93-4492-84F3-823A7688CF6EQ37599994-0A271874-D6F1-4DC2-A5EC-36D78D356FD6Q37608553-E36261B8-C9D1-4BA9-BE27-2D8B07C69F07Q37624464-061C0EDE-4C11-4624-B667-A02E74025DD7Q38405037-CC54970C-8EA2-47C5-ADD0-E8C8B39905FBQ40106829-5D092AC3-6796-482A-BF3D-062096F36FEEQ40902162-EA7CEA28-A384-4834-B449-A2FE69DA5765Q41124292-328B508C-28CD-4C0E-9274-9E28A5032B2BQ41297827-D928B60A-306D-4E96-8A92-246DCD2314E0Q41897903-98DA68E6-9701-4ACC-956F-0A7894A826F9Q42328592-977D6A77-DB7C-4387-96A6-41DA91D1F1E5Q48348693-0EC9917D-7597-4D06-90FE-33AE72D4FE6BQ53072682-CB05BCC4-E57C-4AB2-8569-05B8E1B54B73Q55259726-04EF086B-D189-450B-98F1-AC5A21D8F62AQ57299820-3C1CD1EF-3480-4E68-A9F4-A28B8C3D6F5DQ57299826-4FF0F984-31F8-4DC1-9C12-4E731E31AEA2Q58137679-9CFA6693-7E01-449C-8E6D-C0A3F4A8E767Q58698660-B3A7C3E7-12DC-4449-B5F2-DE74D5CD132BQ59125886-81B82C57-454A-4C2B-8047-B949971C57ADQ60949195-35EF7B90-EB7F-487C-8B89-F4E957913D67Q64064173-C099C942-68EF-4960-A98A-8A41F1C9EAC1Q64065788-D8A06857-61EF-43E0-A6B2-44AF605B6808Q64066106-619C5C12-822C-4910-A63D-B948F89CD73DQ64098805-22494DB6-7011-4F06-B11B-4E2A0FADE2A6Q89588653-52CFC2A9-8674-40BF-AD79-45ECA8C7216FQ89905396-69EDB84C-41B7-4360-9209-C244F612036EQ90397420-4D550C07-D608-4B7E-9E5B-A472CC11EDACQ91592270-FCA65B16-0AED-4C11-B4B8-A9E1C8550446Q91599836-E1DAF182-2574-4DCB-B847-C26EFCE416E6Q92195505-8BD81D99-5050-45BA-89D8-5849F3A9610AQ92236645-E77D2324-7229-4E1F-98BE-995B07476F81
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yeon-Mok Oh
@ast
Yeon-Mok Oh
@en
Yeon-Mok Oh
@es
Yeon-Mok Oh
@nl
type
label
Yeon-Mok Oh
@ast
Yeon-Mok Oh
@en
Yeon-Mok Oh
@es
Yeon-Mok Oh
@nl
prefLabel
Yeon-Mok Oh
@ast
Yeon-Mok Oh
@en
Yeon-Mok Oh
@es
Yeon-Mok Oh
@nl
P106
P1153
7402125922
P31
P496
0000-0003-0116-4683